THIORIDAZINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for thioridazine hydrochloride and what is the scope of patent protection?
Thioridazine hydrochloride
is the generic ingredient in three branded drugs marketed by Novartis, Actavis Mid Atlantic, Alpharma Us Pharms, Ani Pharms, Epic Pharma Llc, Pharm Assoc, Sandoz, Wockhardt, Roxane, Chartwell Rx, Heritage Pharma Avet, Mutual Pharm, Mylan, Par Pharm, Sun Pharm Industries, Superpharm, Watson Labs, Watson Labs Teva, and West Ward, and is included in eighty NDAs. Additional information is available in the individual branded drug profile pages.There are six drug master file entries for thioridazine hydrochloride. Three suppliers are listed for this compound.
Summary for THIORIDAZINE HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 19 |
NDAs: | 80 |
Drug Master File Entries: | 6 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 98 |
Clinical Trials: | 10 |
Patent Applications: | 5,277 |
What excipients (inactive ingredients) are in THIORIDAZINE HYDROCHLORIDE? | THIORIDAZINE HYDROCHLORIDE excipients list |
DailyMed Link: | THIORIDAZINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for THIORIDAZINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rambam Health Care Campus | Early Phase 1 |
Rabin Medical Center | Early Phase 1 |
Astellas Pharma Inc | Phase 4 |
Pharmacology for THIORIDAZINE HYDROCHLORIDE
Drug Class | Phenothiazine |
Anatomical Therapeutic Chemical (ATC) Classes for THIORIDAZINE HYDROCHLORIDE
US Patents and Regulatory Information for THIORIDAZINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharm Assoc | THIORIDAZINE HYDROCHLORIDE | thioridazine hydrochloride | CONCENTRATE;ORAL | 040213-001 | May 29, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | THIORIDAZINE HYDROCHLORIDE | thioridazine hydrochloride | TABLET;ORAL | 088561-001 | May 11, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mutual Pharm | THIORIDAZINE HYDROCHLORIDE | thioridazine hydrochloride | TABLET;ORAL | 087264-001 | Nov 18, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.